Discontinued — last reported Q4 '25

Geographic · Net Sales

Latin Americaand Canada — Net Sales

Boston Scientific Latin Americaand Canada — Net Sales remained flat by 0.0% to $169.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.7%, from $156.00M to $169.50M. Over 4 years (FY 2021 to FY 2025), Latin Americaand Canada — Net Sales shows an upward trend with a 15.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ4 2025
Rolls up toTotal Revenue

How to read this metric

An increase suggests successful market penetration, effective distribution strategies, or rising demand for medical devices in these regions, while a decrease may signal competitive pressure, economic volatility, or regulatory challenges.

Detailed definition

This metric represents the total revenue generated from the sale of medical devices and related services within the Lati...

Peer comparison

Peers in the medical device industry typically report geographic revenue segments to highlight regional growth trends and exposure to emerging versus developed market dynamics.

Metric ID: bsx_segment_latin_america_and_canada_net_sales

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$386.00M$469.00M$560.00M$624.00M$678.00M
YoY Change+21.5%+19.4%+11.4%+8.7%
Range$386.00M$678.00M
CAGR+15.1%
Avg YoY Growth+15.2%
Median YoY Growth+15.4%
Current Streak4+ years growth

Frequently Asked Questions

What is Boston Scientific's latin americaand canada — net sales?
Boston Scientific (BSX) reported latin americaand canada — net sales of $169.50M in Q4 2025.
How has Boston Scientific's latin americaand canada — net sales changed year-over-year?
Boston Scientific's latin americaand canada — net sales increased by 8.7% year-over-year, from $156.00M to $169.50M.
What is the long-term trend for Boston Scientific's latin americaand canada — net sales?
Over 4 years (2021 to 2025), Boston Scientific's latin americaand canada — net sales has grown at a 15.1% compound annual growth rate (CAGR), from $386.00M to $678.00M.
What does latin americaand canada — net sales mean?
The total revenue earned from products sold in the Latin American and Canadian markets.